Silver colloidal nanoparticles: antifungal effect against adhered cells and biofilms of Candida albicans and Candida glabrata

The aim of this study was to evaluate the effect of silver nanoparticles (SN) against Candida albicans and Candida glabrata adhered cells and biofilms. SN (average diameter 5 nm) were synthesized by silver nitrate reduction with sodium citrate and stabilized with ammonia. Minimal inhibitory concentration (MIC) tests were performed for C. albicans (n = 2) and C. glabrata (n = 2) grown in suspension following the Clinical Laboratory Standards Institute microbroth dilution method. SN were applied to adhered cells (2 h) or biofilms (48 h) and after 24 h of contact their effect was assessed by enumeration of colony forming units (CFUs) and quantification of total biomass (by crystal violet staining). The MIC results showed that SN were fungicidal against all strains tested at very low concentrations (0.4–3.3 μg ml−1). Furthermore, SN were more effective in reducing biofilm biomass when applied to adhered cells (2 h) than to pre-formed biofilms (48 h), with the exception of C. glabrata ATCC, which in both cases showed a reduction ∼90%. Regarding cell viability, SN were highly effective on adhered C. glabrata and respective biofilms. On C. albicans the effect was not so evident but there was also a reduction in the number of viable biofilm cells. In summary, SN may have the potential to be an effective alternative to conventional antifungal agents for future therapies in Candida-associated denture stomatitis.

[1]  N. Jain,et al.  Biofilm formation in clinical Candida isolates and its association with virulence. , 2009, Microbes and infection.

[2]  M. Yacamán,et al.  Interaction of silver nanoparticles with HIV-1 , 2005, Journal of nanobiotechnology.

[3]  David W Williams,et al.  In Vitro Biofilm Activity of Non-Candida albicansCandida Species , 2010, Current Microbiology.

[4]  W. Xu,et al.  Study on the interaction between silver nanoparticles and nucleic acids in the presence of cetyltrimethylammonium bromide and its analytical application. , 2008, Talanta.

[5]  J. Bagg,et al.  High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer , 2003, Palliative medicine.

[6]  L. Samaranayake,et al.  Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms. , 2009, Archives of oral biology.

[7]  E. Budtz-Jörgensen.  Candida-associated denture stomatitis and angular cheilitis. , 1990 .

[8]  I. Beyer,et al.  Denture contamination by yeasts in the elderly. , 2008, Gerodontology.

[9]  L. Samaranayake,et al.  In Vitro Method To Study Antifungal Perfusion in Candida Biofilms , 2005, Journal of Clinical Microbiology.

[10]  Chi-Ming Che,et al.  Proteomic analysis of the mode of antibacterial action of silver nanoparticles. , 2006, Journal of proteome research.

[11]  S. Hinder,et al.  Prevention of Staphylococcus epidermidis biofilm formation using a low-temperature processed silver-doped phenyltriethoxysilane sol-gel coating. , 2008, Biomaterials.

[12]  C. Hollenstein,et al.  Inhibition of bacterial adhesion on PVC endotracheal tubes by RF-oxygen glow discharge, sodium hydroxide and silver nitrate treatments. , 2004, Biomaterials.

[13]  L. F. Gorup,et al.  International Journal of Antimicrobial Agents the Growing Importance of Materials That Prevent Microbial Adhesion: Antimicrobial Effect of Medical Devices Containing Silver , 2022 .

[14]  Sureshbabu Ram Kumar Pandian,et al.  Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. , 2010, Colloids and surfaces. B, Biointerfaces.

[15]  M. Givskov,et al.  Silver against Pseudomonas aeruginosa biofilms , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[16]  L. Samaranayake,et al.  Oral mucosal fungal infections. , 2009, Periodontology 2000.

[17]  Darrin J Pochan,et al.  Synthesis and antibacterial properties of silver nanoparticles. , 2005, Journal of nanoscience and nanotechnology.

[18]  P. Hamal,et al.  Antifungal activity of silver nanoparticles against Candida spp. , 2009, Biomaterials.

[19]  J. Lopez-Ribot,et al.  Candida Biofilms: an Update , 2005, Eukaryotic Cell.

[20]  D. G. Lee,et al.  Antifungal activity and mode of action of silver nano-particles on Candida albicans , 2009, BioMetals.

[21]  Y. Abiko,et al.  Proteomics of drug resistance in Candida glabrata biofilms , 2010, Proteomics.

[22]  W. Graninger,et al.  In vitro activity of antifungal combinations against Candida albicans biofilms. , 2010, The Journal of antimicrobial chemotherapy.

[23]  W. Youngs,et al.  Silver and its application as an antimicrobial agent , 2005 .

[24]  S. Porter,et al.  Formation of Candida albicans biofilms on non-shedding oral surfaces. , 2003, European journal of oral sciences.

[25]  D. G. Lee,et al.  Antifungal effect of silver nanoparticles on dermatophytes. , 2008, Journal of microbiology and biotechnology.

[26]  C. C. Lin,et al.  Denture stomatitis--a review of the aetiology, diagnosis and management. , 1992, Australian dental journal.

[27]  Helmut Münstedt,et al.  The antimicrobial efficacy of polyamide 6/silver-nano- and microcomposites , 2008 .

[28]  I. Sondi,et al.  Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. , 2004, Journal of colloid and interface science.

[29]  Mahmoud A. Ghannoum,et al.  Biofilm Formation by the Fungal PathogenCandida albicans: Development, Architecture, and Drug Resistance , 2001, Journal of bacteriology.

[30]  M. Hande,et al.  Cytotoxicity and genotoxicity of silver nanoparticles in human cells. , 2009, ACS nano.

[31]  R. L. Jones,et al.  Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. , 2008, The journal of physical chemistry. B.

[32]  H. Yatani,et al.  Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans. , 2009, International journal of antimicrobial agents.

[33]  G. O’Toole,et al.  Mechanisms of biofilm resistance to antimicrobial agents. , 2001, Trends in microbiology.

[34]  J. Bagg,et al.  Mixed Candida albicans and Candida glabrata populations associated with the pathogenesis of denture stomatitis. , 2008, Oral microbiology and immunology.

[35]  L. F. Gorup,et al.  Moderating effect of ammonia on particle growth and stability of quasi-monodisperse silver nanoparticles synthesized by the Turkevich method. , 2011, Journal of colloid and interface science.

[36]  J. Song,et al.  Does the Antibacterial Activity of Silver Nanoparticles Depend on the Shape of the Nanoparticle? A Study of the Gram-Negative Bacterium Escherichia coli , 2007, Applied and Environmental Microbiology.

[37]  B. Wickes,et al.  Denture stomatitis: a role for Candida biofilms. , 2004, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[38]  M. Rai,et al.  Silver nanoparticles as a new generation of antimicrobials. , 2009, Biotechnology advances.

[39]  B. C. Webb,et al.  Candida-associated denture stomatitis. Aetiology and management: a review. Part 2. Oral diseases caused by Candida species. , 1998, Australian dental journal.

[40]  M. Pascale,et al.  Candida-associated denture stomatitis. , 2011, Medicina oral, patologia oral y cirugia bucal.

[41]  H. Nelis,et al.  Fungicidal activity of miconazole against Candida spp. biofilms. , 2010, The Journal of antimicrobial chemotherapy.

[42]  J. Hillier,et al.  A study of the nucleation and growth processes in the synthesis of colloidal gold , 1951 .

[43]  H. Ceri,et al.  Metal resistance in Candida biofilms. , 2006, FEMS microbiology ecology.